Celsion (CLSN) Tops Q3 EPS by 7c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. VRTX
4. CHKP
5. ON
6. CRWD
7. HNGE
8. INSP
9. MTCH
10. CVI

Go back to Celsion (CLSN) Tops Q3 EPS by 7c

Celsion Corporation Reports Third Quarter 2015 Financial Results and Provides Business Update

November 5, 2015 8:00 AM EST

LAWRENCEVILLE, N.J., Nov. 5, 2015 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced financial results for the quarter ended September 30, 2015 and provided an update on its development programs, including ThermoDox®, its proprietary heat-activated liposomal encapsulation of doxorubicin, and GEN-1, an IL-12 DNA-based immunotherapy encased in a synthetic nanoparticle delivery system, which minimizes toxicity and maximizes the multiple antitumor effects of IL-12 and is currently under development for the localized treatment of ovarian and brain cancers. 

"During the past quarter, we reported positive data highlighting the multiple development... More